Group 1 - The core viewpoint of the news is that Nanmo Biological has seen a stock price increase of 5.09%, reaching 48.35 yuan per share, with a total market capitalization of 3.77 billion yuan [1] - Nanmo Biological, established on September 20, 2000, specializes in the research, production, and sales of genetically modified animal models, with its main business revenue composition being: standardized models 48.34%, model technical services 21.92%, model breeding 19.50%, customized models 9.34%, and others 0.91% [1] Group 2 - Tianhong Fund's Tianhong Medical Health A (001558) has entered the top ten circulating shareholders of Nanmo Biological, holding 377,400 shares, which is 0.48% of the circulating shares, with an estimated floating profit of approximately 883,200 yuan [2] - Tianhong Medical Health A was established on June 30, 2015, with a latest scale of 263 million yuan, and has achieved a year-to-date return of 36.83% [2] Group 3 - The fund manager of Tianhong Medical Health A is Lü Qiao, who has a total fund asset scale of 506 million yuan, with the best fund return during the tenure being 41.15% and the worst being 40.68% [3]

Core Viewpoint - The announcement of fund manager Guo Xiangbo's departure from Tianhong Fund on October 14, 2025, due to personal reasons, marks a significant change in the management of Tianhong's healthcare-related funds [2][4]. Group 1: Fund Manager Departure - Guo Xiangbo has left his position as the fund manager for Tianhong Medical Innovation and Tianhong Selected Health, effective October 14, 2025 [2][4]. - Guo Xiangbo has been with Tianhong Fund for 11 years, having joined in February 2014, and previously served as the Director of Health Investment [4][5]. - During his tenure, Guo managed four funds, with the longest management period being for Tianhong Medical Health A, which achieved a return of 55.89% over 7 years [4][6]. Group 2: Fund Performance - The annualized returns for Tianhong Medical Innovation A and Tianhong Selected Health A are 2.45% and 7.27%, respectively, with both funds ranking in the top 50% of their peers [4][6]. - Tianhong Medical Health A, managed by Guo, has a return ranking of 163 out of 497 similar funds [4][6]. - Guo's managed assets were valued at 1.243 billion yuan before his departure, having peaked at over 2.1 billion yuan at the end of 2021 [5][6].